Endogenously Produced SARS-CoV-2 Specific IgG Antibodies May Have a Limited Impact on Clearing Nasal Shedding of Virus during Primary Infection in Humans

While SARS-CoV-2 specific neutralizing antibodies have been developed for therapeutic purposes, the specific viral triggers that drive the generation of SARS-CoV-2 specific IgG and IgM antibodies remain only partially characterized. Moreover, it is unknown whether endogenously derived antibodies dri...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shuyi, Jerome, Keith R., Greninger, Alexander L., Schiffer, Joshua T., Goyal, Ashish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003723/
https://www.ncbi.nlm.nih.gov/pubmed/33804667
http://dx.doi.org/10.3390/v13030516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003723/
https://www.ncbi.nlm.nih.gov/pubmed/33804667
http://dx.doi.org/10.3390/v13030516

Ejemplares similares